FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008404149> ?p ?o ?g. }

• W2008404149 endingPage "407" @default.
• W2008404149 startingPage "391" @default.
• W2008404149 abstract "Summary— Cardiac arrhythmias and sudden death have been associated with both therapeutic and toxic doses of a number of cardiotropic and non-cardiac drugs. Generally the drug-induced electrocardiographic (ECG) alterations have been well described, whereas corresponding cellular electrophysiological effects are poorly documented or lacking. Taking into account the recent advances in the understanding of the mechanisms underlying arrhythmias and antiarrhythmic effects, suitable relationships can be established between ECG alterations and drug effects on cardiac action potential. Thus, a decrease in maximal upstroke velocity (Vmax) and membrane depolarisation leading to cellular inexcitability may slow conduction, prolong QRS interval duration and result in incessant wide QRS ventricular tachycardia. On the other hand, lengthening of the repolarisation phase and early afterdepolarisations (EADs) have been proposed as a mechanism for prolonged QT interval and subsequent Torsades de Pointes. A representative study aimed at detecting the arrhythmogenic potentiality of a drug is given, by examining carefully the concentration- and frequency-dependent effects of four neuroleptics (sultopride, droperidol, thioridazine and clozapine) on Purkinje fibers and comparing them with the reported iatrogenic arrhythmias. The results showed that 10 to 100 μM sultopride and 0.01 to 1 μM droperidol exerted “pure” class III effects. In addition, higher concentrations (3 to 30 μM) of droperidol reversed the prolonging effect on repolarisation concomitantly with a dose- and frequency-dependent decrease in Vmax, action potential amplitude and resting membrane potential (class I effects) resulting in cellular inexcitability at 30 μM. Similar class I effects were induced by thioridazine and clozapine concomitantly with a slight prolonging effect on final repolarisation (class la effects). In the presence of sultopride (30 and 100 μM) and droperidol (0.3 to 3 μM), EADs developed at plateau level. Their incidence, amplitude and number were influenced by extracellular K or Mg concentration, stimulation frequency, modification of Ca entry (by nifedipine or isoproterenol). These experimental results fit well with clinical data although they need further development to precise underlying ionic mechanisms. Therefore, in vitro studies should be considered before clinical prospects for future drug development." @default.
• W2008404149 created "2016-06-24" @default.
• W2008404149 creator A5048037726 @default.
• W2008404149 creator A5049331643 @default.
• W2008404149 creator A5076990300 @default.
• W2008404149 date "1994-09-10" @default.
• W2008404149 modified "2023-09-27" @default.
• W2008404149 title "<i>In vitro</i>electrophysiological detection of iatrogenic arrhythmogenicity" @default.
• W2008404149 cites W1964002372 @default.
• W2008404149 cites W1965079396 @default.
• W2008404149 cites W1967151871 @default.
• W2008404149 cites W1971630146 @default.
• W2008404149 cites W1972973700 @default.
• W2008404149 cites W1986728006 @default.
• W2008404149 cites W1995283277 @default.
• W2008404149 cites W2002374666 @default.
• W2008404149 cites W2003264967 @default.
• W2008404149 cites W2006112946 @default.
• W2008404149 cites W2006153263 @default.
• W2008404149 cites W2006199155 @default.
• W2008404149 cites W2009996971 @default.
• W2008404149 cites W2014575044 @default.
• W2008404149 cites W2026501479 @default.
• W2008404149 cites W2028721157 @default.
• W2008404149 cites W2033071915 @default.
• W2008404149 cites W2046893534 @default.
• W2008404149 cites W2048893115 @default.
• W2008404149 cites W2061101834 @default.
• W2008404149 cites W2062554552 @default.
• W2008404149 cites W2068795851 @default.
• W2008404149 cites W2069640754 @default.
• W2008404149 cites W2072797200 @default.
• W2008404149 cites W2080811832 @default.
• W2008404149 cites W2080963609 @default.
• W2008404149 cites W2083966894 @default.
• W2008404149 cites W2087234566 @default.
• W2008404149 cites W2089226644 @default.
• W2008404149 cites W2089419875 @default.
• W2008404149 cites W2115827974 @default.
• W2008404149 cites W2135225379 @default.
• W2008404149 cites W2155932859 @default.
• W2008404149 cites W2165380669 @default.
• W2008404149 cites W2463417997 @default.
• W2008404149 cites W2614168425 @default.
• W2008404149 cites W4247558682 @default.
• W2008404149 doi "https://doi.org/10.1111/j.1472-8206.1994.tb00818.x" @default.
• W2008404149 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7875633" @default.
• W2008404149 hasPublicationYear "1994" @default.
• W2008404149 type Work @default.
• W2008404149 sameAs 2008404149 @default.
• W2008404149 citedByCount "38" @default.
• W2008404149 countsByYear W20084041492022 @default.
• W2008404149 crossrefType "journal-article" @default.
• W2008404149 hasAuthorship W2008404149A5048037726 @default.
• W2008404149 hasAuthorship W2008404149A5049331643 @default.
• W2008404149 hasAuthorship W2008404149A5076990300 @default.
• W2008404149 hasConcept C111773187 @default.
• W2008404149 hasConcept C118441451 @default.
• W2008404149 hasConcept C118552586 @default.
• W2008404149 hasConcept C126322002 @default.
• W2008404149 hasConcept C146403970 @default.
• W2008404149 hasConcept C155730078 @default.
• W2008404149 hasConcept C164705383 @default.
• W2008404149 hasConcept C178697064 @default.
• W2008404149 hasConcept C185263204 @default.
• W2008404149 hasConcept C2776331378 @default.
• W2008404149 hasConcept C2776412080 @default.
• W2008404149 hasConcept C2777463368 @default.
• W2008404149 hasConcept C2777953023 @default.
• W2008404149 hasConcept C2778775820 @default.
• W2008404149 hasConcept C2779425338 @default.
• W2008404149 hasConcept C2780035454 @default.
• W2008404149 hasConcept C2780486423 @default.
• W2008404149 hasConcept C2780688371 @default.
• W2008404149 hasConcept C2780864610 @default.
• W2008404149 hasConcept C2781072394 @default.
• W2008404149 hasConcept C4141045 @default.
• W2008404149 hasConcept C42219234 @default.
• W2008404149 hasConcept C61381695 @default.
• W2008404149 hasConcept C71924100 @default.
• W2008404149 hasConcept C84393581 @default.
• W2008404149 hasConcept C98274493 @default.
• W2008404149 hasConceptScore W2008404149C111773187 @default.
• W2008404149 hasConceptScore W2008404149C118441451 @default.
• W2008404149 hasConceptScore W2008404149C118552586 @default.
• W2008404149 hasConceptScore W2008404149C126322002 @default.
• W2008404149 hasConceptScore W2008404149C146403970 @default.
• W2008404149 hasConceptScore W2008404149C155730078 @default.
• W2008404149 hasConceptScore W2008404149C164705383 @default.
• W2008404149 hasConceptScore W2008404149C178697064 @default.
• W2008404149 hasConceptScore W2008404149C185263204 @default.
• W2008404149 hasConceptScore W2008404149C2776331378 @default.
• W2008404149 hasConceptScore W2008404149C2776412080 @default.
• W2008404149 hasConceptScore W2008404149C2777463368 @default.
• W2008404149 hasConceptScore W2008404149C2777953023 @default.
• W2008404149 hasConceptScore W2008404149C2778775820 @default.
• W2008404149 hasConceptScore W2008404149C2779425338 @default.
• W2008404149 hasConceptScore W2008404149C2780035454 @default.

• next